Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSF2000010	精蛋白重组人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-04-21	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-05-11	view
JYSB2000164	精蛋白重组人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-05-09	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-05-28	view
CXSL2000103	精蛋白重组人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products(15)	New Drug Application	2020-05-18	吉林惠升生物制药有限公司	Jilin Huisheng Biopharmaceutical Co Ltd	In Review	2020-05-15	view
JYSB2000213	精蛋白重组人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-05-28	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-06-04	view
JYSB2000220	精蛋白重组人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2020-05-29	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-06-04	view
JYSZ2100006	精蛋白重组人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-03-12	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-08-04	view
JYSZ2100008	精蛋白重组人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-03-20	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-08-04	view